EUVIMEDEUVIMED entdecken
Crossref

Severity Matters: Injury Severity May Limit the Protective Association of Pre-injury Statin Therapy After Traumatic Brain Injury

Hope E Werenski iD, Miles Reese iD, Debra I Diz, Taylor V Sabato iD, J Jason Hoth, Gregory R Stettler

The American Surgeon™ · 30.07.2026

DOI: 10.1177/00031348261474183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 30.07.2026. Verfasst von Hope E Werenski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Atrium Health Wake Forest Baptist Hospital, Winston-Salem, NC, USA. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Severe traumatic brain injury (TBI) is the leading cause of injury-related mortality. Prior studies suggest statin medications may be associated with favorable outcomes after TBI and reduced risk of venous thromboembolism. However, the effects of statin medications in patients with severe TBI have not been evaluated. The objective of this study is to determine the effects of pre-injury statin exposure on injured patients with severe TBI.

Methods

Adult trauma patients with severe TBI (GCS≤8) who received pre-injury statins were compared to those who did not receive pre-injury statins. Demographics, complication rates, blood product transfusion volumes, and mortality were evaluated. Univariate and multivariable analyses were used to determine independent predictors of mortality.

Results

A total of 816 patients suffered a severe TBI during the study period. Of these, 151 patients (18.5%) were taking statin medications prior to injury. Patients with pre-injury statin exposure had lower early mortality than those without pre-injury exposure (6.6% vs 12.8%, P = 0.04). After adjusting for baseline differences, pre-injury statin use was not an independent predictor of mortality following multiple logistic regression. In subgroup analyses, pre-injury statin exposure was not associated with improved outcomes in those who received a blood transfusion or were in shock.

Conclusion

Although pre-injury statin exposure was associated with lower unadjusted early mortality in patients with severe TBI, this association did not persist after adjustment for injury severity and physiologic differences. These findings suggest that potential benefits observed in broader TBI populations may not extend to patients with severe TBI.

Schlagwörter

Stichwörter der Autor:innen

ARDSstatinstraumatraumatic brain injury

Autor:innen und Institutionen

  • Department of Surgery, Atrium Health Wake Forest Baptist Hospital, Winston-Salem, NC, USA.
  • Department of Surgery, Division of Trauma and Acute Care Surgery, Atrium Health Wake Forest BaptistHospital, Winston-Salem, NC, USA.
  • Deparment of Surgery, Section of Hypertension, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Wake Forest University School of Medicine, Winston-Salem, NC, USA.

ORCID-Profile: Hope E Werenski, Miles Reese, Taylor V Sabato

Zitieren

APA

Werenski, H. E., Reese, M., Diz, D. I., Sabato, T. V., Hoth, J. J., & Stettler, G. R. (2026). Severity Matters: Injury Severity May Limit the Protective Association of Pre-injury Statin Therapy After Traumatic Brain Injury. The American Surgeon™. https://doi.org/10.1177/00031348261474183

Vancouver

Werenski HE, Reese M, Diz DI, Sabato TV, Hoth JJ, Stettler GR. Severity Matters: Injury Severity May Limit the Protective Association of Pre-injury Statin Therapy After Traumatic Brain Injury. The American Surgeon™. 2026. doi:10.1177/00031348261474183

BibTeX
@article{Werenski2026,
  author = {Werenski, Hope E and Reese, Miles and Diz, Debra I and Sabato, Taylor V and Hoth, J Jason and Stettler, Gregory R},
  title = {Severity Matters: Injury Severity May Limit the Protective Association of Pre-injury Statin Therapy After Traumatic Brain Injury},
  journal = {The American Surgeon™},
  year = {2026},
  doi = {10.1177/00031348261474183}
}
Kostenlos starten →